ArticleOncoTargets and therapy2019

Should S-1 be better than capecitabine for patients with advanced gastric cancer in Asia? A systematic review and meta-analysis.

Ziqi Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.